ABSTRACT
Objective To describe patterns and socioeconomic inequalities in complementary feeding practices among children aged 6-23 months in 80 low and middle-income countries (LMICs).
Methods We analyzed national surveys carried out since 2010. Complementary feeding indicators for children aged 6-23 months included minimum dietary diversity (MDD), minimum meal frequency (MMF) and minimum acceptable diet (MAD). Between- and within-country inequalities were documented using relative (wealth deciles) and absolute (estimated household income) socioeconomic indicators.
Results Only 21.3%, 56.2% and 10.1% of the 80 countries showed prevalence levels above 50% for MDD, MMF and MAD, respectively. Western & Central Africa showed the lowest prevalence for all indicators, whereas the highest for MDD and MAD was Latin America & Caribbean, and for MMF in East Asia & the Pacific. Log per capita gross domestic product was positively associated with MDD (R2 = 48.5%), MMF (28.2%) and MAD (41.4%). Pro-rich within-country inequalities were observed in most countries for the three indicators; pro-poor inequalities were observed in two countries for MMF, and in none for the other two indicators. Breastmilk was the only type of food with a pro-poor distribution, whereas animal-source foods (dairy products, flesh foods and eggs) showed the most pronounced pro-rich inequality. Dietary diversity improved sharply when absolute annual household incomes exceeded about US$20,000. There were no consistent differences among boys and girls for any of the indicators studied.
Conclusion Monitoring complementary feeding indicators in the world and implementing policies and programs to reduce wealth-related inequalities are essential to achieve optimal child nutrition.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This paper was supported by the Bill & Melinda Gates Foundation (Coverage & Equity of RMNCAH Outcomes: Research & Analysis from Pelotas) under Grant OPP1199234, by the Wellcome Trust (grant 101815/Z/13/Z and by ABRASCO (Associacao Brasileira de Saude Coletiva).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The data used in our analyses are publicly available, and the institutions that conducted the surveys in each country handled the respective ethical clearance.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
e-mail: ggatica{at}gmail.com;
e-mail: paugustorn{at}gmail.com;
e-mail: abarros{at}equidade.org;
e-mail: cvictora{at}equidade.org;
Funding. This paper was supported by the Bill & Melinda Gates Foundation (Coverage & Equity of RMNCAH Outcomes: Research & Analysis from Pelotas) under Grant OPP1199234, by the Wellcome Trust (grant 101815/Z/13/Z and by ABRASCO (Associação Brasileira de Saúde Coletiva).
Disclosure statement. The authors reported no potential conflict of interest
Data Availability
The dataset is publicly available.
